This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel bispecific immunotherapy, and more.
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Cooling and compression help manage common side effect of chemotherapy, and deadlines encourage people to complete colorectal cancer screening.
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he started radiation therapy. His oncologist told him he might be eligible for targeted therapy, but...
Pickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
HPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.
Natalie Snider-Hoy, a PhD candidate at Wayne State University, attended AACR Early-career Hill Day 2025 to advocate for sustained NIH funding.
Cancer screenings are key to saving lives. Take colonoscopies, for example, which are estimated to reduce colorectal cancer risk by about 30%. This is because undergoing colonoscopies as recommended (every 10 years beginning at...
Exercise associated with increased survival after colon cancer, and screening costs remain a hurdle for women with dense breasts.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now